share_log

Evaluating BeiGene: Insights From 6 Financial Analysts

Benzinga ·  Apr 24 14:01

In the last three months, 6 analysts have published ratings on BeiGene (NASDAQ:BGNE), offering a diverse range of perspectives from bullish to bearish.

The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings22200
Last 30D10000
1M Ago00200
2M Ago11000
3M Ago01000

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $212.88, along with a high estimate of $345.00 and a low estimate of $161.00. A decline of 6.98% from the prior average price target is evident in the current average.

price target chart

Decoding Analyst Ratings: A Detailed Look

The perception of BeiGene by...

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment